§ Player · Midfielder

Miguel Menino

Farense

In the 2024-25 Liga Portugal, Miguel Menino has an NVP of 26: number 79 of 83 midfielders in the league with 900+ minutes.

They produce 0.70 times their position's average and cost 0.98 times as much.

Their strongest skill is Striker: B, percentile 65.

They have a rating in 26 matches that season and were player of the match in 0. Their best rating was 61, in Estoril 2–2 Farense.

Seasons

SeasonCompetitionTeamMinGAProducesCostsNVP
2024-25 Liga Portugal Farense 184520 0.70× 0.98× 26

Skills

Percentile against players in the same position in the 2024-25 Liga Portugal, as on the app card.

StrikerB65
CreatorX7
DribblerX29
DefenderX28
ControlX5

Latest matches

  1. 42 Farense 0–1 Boavista18 Apr · Liga Portugal · 61'
  2. 55 Estrela Amadora 0–1 Farense13 Apr · Liga Portugal · 86'
  3. 51 Farense 0–0 Casa Pia7 Apr · Liga Portugal · 90'
  4. 46 Benfica 3–2 Farense2 Apr · Liga Portugal · 67'
  5. 61 Estoril 2–2 Farense8 Mar · Liga Portugal · 29'
  6. 38 Farense 0–1 AVS2 Mar · Liga Portugal · 90'
  7. 46 Arouca 2–2 Farense23 Feb · Liga Portugal · 88'
  8. 55 Farense 0–1 Porto16 Feb · Liga Portugal · 82'
  9. 49 Farense 0–2 Nacional9 Feb · Liga Portugal · 57'
  10. 37 Sporting CP 3–1 Farense2 Feb · Liga Portugal · 76'

Best matches

  1. 61 Estoril 2–2 Farense8 Mar 2025 · Liga Portugal
  2. 55 Farense 0–1 Porto16 Feb 2025 · Liga Portugal
  3. 55 Estrela Amadora 0–1 Farense13 Apr 2025 · Liga Portugal
  4. 52 Famalicão 1–2 Farense21 Dec 2024 · Liga Portugal
  5. 51 Farense 1–0 Estrela Amadora29 Nov 2024 · Liga Portugal

How is the rating calculated?

The rating measures a single match: what the player produced against what they cost, compared with the average for their position in that league and season, and adjusted by position (a 70 for a forward is as hard to get as a 70 for a defender). A normal match is around 50, 70 is already very good and only one in a hundred goes above 80. It is not the NVP, which ranks the whole season.

See their card in La Lente All their metrics, recent form, comparisons and Same DNA.